封面
市場調查報告書
商品編碼
1404777

微流體市場規模、佔有率、趨勢分析報告:按應用、材料、技術、地區、細分市場預測,2024-2030

Microfluidics Market Size, Share & Trends Analysis Report By Application (Medical/Healthcare, Non-Medical), By Material (Silicon, Glass), By Technology, By Region, And Segment Forecasts, 2024 - 2030

出版日期: | 出版商: Grand View Research | 英文 200 Pages | 商品交期: 2-10個工作天內

價格

微流控市場成長與趨勢:

根據Grand View Research, Inc.最新報告,預計2030年全球微流控市場規模將達719億美元,2024年至2030年複合年成長率為12.22%。

晶載微流體等改進技術的引入預計將增加對基於微流體的設備的需求。分析和臨床研究人員研究活動的增加也推動了對微流體設備的需求。例如,2022 年 5 月,明尼蘇達大學的一組研究人員開發了一種用於疾病診斷的創新微流控晶片,該晶片使用最少的組件,並且可以透過智慧型手機無線操作。

基於小型微流體的工具在消費者中越來越受歡迎,這促使公司對其開發進行投資。由於微流控是晶片實驗室設備的基本原理,因此它具有許多優點,例如最小的樣品體積、最少的試劑用量、減少廢棄物和快速處理。增強型全自動微流體和強大的模組化正在為該市場中的製造商創造成長機會。這是因為模組化晶片可以與多個設備連接。此外,在藥物研發領域運作的公司正在努力最大限度地減少管理費用和時間表,以抵消由於專利到期的藥物數量而導致的預期收益下降。

微流控在診斷領域的應用正在擴大,特別是在 POC 診斷中。微流控整合生物感測器技術也對此進行了補充,預計將增強 POC 診斷。微流控元件與POC設備的結合致力於實現靈敏度、穩定性、精確性、經濟性,並獲得微創POC技術。微流控 POC 技術有望透過確保個體化、早期發現疾病和輕鬆監測來增強患者護理。

此外,COVID-19 進一步擴大了微流體的使用範圍。現場護理測試使用小型設備、受控流程和有限的檢查週期。這使得單一或多個研究實驗室服務能夠同時評估生物樣本並診斷有害疾病。總的來說,階段評估和快速發現病毒爆發對於克服疫情並快速診斷至關重要。因此,將微流體裝置與即時檢測相結合可以提高檢測效率。同時,使用微流控晶片進行現場檢測增加了用戶便利性,提高了靈敏度和準確性,並減少了檢測時間。

此外,微流體產業的幾項收購旨在增強技術,以擴大微流體相關應用的範圍。 2021 年 6 月,丹納赫公司宣布其生命科學業務收購了加拿大解決方案供應商 Precision Nanosystems (PNI)。 PNI 提供獨特的遺傳套件平台,包括透過基於微流體的平台進行 LNP 輸送和奈米顆粒製造,進一步補充了該公司的生命科學產品系列。

另一方面,高昂的營運成本在一定程度上阻礙了微流控市場的成長。微流控晶片的製造面臨挑戰,例如需要黏合機械部件以形成最終密封結構的開放通道結構。開放通道是透過蝕刻玻璃或矽形成的。此步驟耗時、昂貴,並且需要使用腐蝕性化學物質。此外,大多數微流體原型製作方法與批量過程不相容,且複雜且昂貴。

微流體市場報告亮點

  • 從應用來看,醫療細分市場將在2023年佔據市場最高收益佔有率佔有率,2024-2030年複合年成長率為12.56%。
  • 從材料來看,聚二甲基矽氧烷(PDMS)領域預計將在2023年佔據最高的市場佔有率,2024年至2030年的複合年成長率為13.59%。
  • 從技術角度來看,晶載領域預計將在 2023 年佔據市場主導地位,預測期內複合年成長率為 11.06%。
  • 預計到 2023 年,北美將主導市場,收益佔有率為 42.69%,預測期內複合年成長率為 10.57%。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章市場變數、趨勢和範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場抑制因素分析
    • 市場機會分析
  • 產業分析工具
    • SWOT 分析;按因素(政治/法律、經濟/技術)
    • 波特五力分析
  • COVID-19感染疾病的影響分析

第4章微流控市場:應用業務分析

  • 微流控市場:應用變化分析
  • 醫療保健
    • PCR和RT-PCR
    • 凝膠電泳
    • 微陣列
    • 酵素連結免疫吸附試驗
    • 其他
  • 非醫療用途

第5章微流體市場:材料業務分析

  • 微流控市場:材料變化分析
  • 玻璃
  • 聚合物
  • 聚二甲基矽氧烷 (PDMS)
  • 其他

第6章微流體市場:技術業務分析

  • 微流控市場:技術變遷分析
  • 晶載實驗室
    • 醫療保健
    • 非醫療的
  • 晶載的器官
    • 醫療保健
    • 非醫療的
  • 連續流微流體
    • 醫療保健
    • 非醫療的
  • 光流控和微流控
    • 醫療保健
    • 非醫療的
  • 聲流體學和微流體學
    • 醫療保健
    • 非醫療的
  • 電泳和微流體
    • 醫療保健
    • 非醫療的

第7章 區域業務分析

  • 2023 年及 2030 年微流控市場佔有率(按地區)
  • 北美洲
    • 北美微流控市場,2018-2030
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲微流控市場,2018-2030
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 亞太微流控市場,2018-2030
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • 拉丁美洲微流控市場,2018-2030
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東/非洲
    • MEA微流控市場,2018-2030
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章競爭形勢

  • 公司分類
  • 策略規劃
  • 2023 年企業市場分析
  • 公司簡介
    • Illumina, Inc.
    • F. Hoffmann-La Roche Ltd
    • PerkinElmer, Inc
    • Agilent Technologies, Inc
    • Bio-Rad Laboratories, Inc
    • Danaher Corporation
    • Abbott
    • Thermo Fisher Scientific Inc.
    • Standard BioTools, Inc.
Product Code: GVR-1-68038-056-9

Microfluidics Market Growth & Trends:

The global microfluidics market size is expected to reach USD 71.90 billion by 2030, registering CAGR of 12.22% from 2024 to 2030, according to a new report by Grand View Research, Inc. The demand for microfluidics-based devices is expected to increase due to the introduction of improved technology such as digital microfluidics, which enables on-chip biochemical analysis. An increase in research activities undertaken by analytical and clinical researchers have also driven the demand for microfluidics device. For instance, in May 2022, a research team from the University of Minnesota developed an innovative microfluidic chip for disease diagnosing that uses a minimum number of components and can be operated wirelessly by a smartphone.

Miniature microfluidic-based tools are gaining significant popularity among consumers, which has encouraged companies to invest in their development. Since microfluidics is the underlying principle of lab-on-a-chip devices, it offers various benefits such as minimal sample volume, minimal reagent usage, reduced waste, and rapid processing. Fully automated microfluidics with enhanced functional capabilities, and robust modularity are creating growth opportunities for manufacturers operating in the market. This can be attributed to the fact that modular chips can interface with several instruments. In addition, companies operating in the field of drug discovery are striving to minimize overhead costs and timelines to offset the estimated decline in revenue owing to a significant number of drugs going off-patent.

The implementation of microfluidics is expanding in the field of diagnostics, especially in POC diagnostics. This is also supplemented by microfluidics-integrated biosensor technologies that are expected to enhance POC diagnostics. The combination of microfluidic components with POC devices is largely focused on achieving sensitivity, stability, accuracy, affordability, and obtaining minimally invasive POC technology. Microfluidic POC technologies are expected to enhance patient care by ensuring personalization, early disease detection, and easy monitoring.

In addition, COVID-19 has further upscaled the use of microfluidics. Point-of-care testing involves small equipment, regulates the process, and has limited testing cycles. This allows single or multiple research laboratory services to evaluate biological samples and diagnose harmful diseases simultaneously. In general, stage assessment and rapid detection of viral epidemics are vital to overcoming pandemic situations and diagnosing rapidly. Therefore, combining microfluidic devices with point-of-care testing enhances detection efficiency. At the same time, point-of-care testing of microfluidic chips enhances user accessibility, improves sensitivity and accuracy, and reduces the detection time, all of which are advantageous in detecting SARS-CoV-2.

Further, several acquisitions in the microfluidics industry are aimed at enhancing technologies for expanding the scope of microfluidics-related applications. In June 2021, Danaher Corporation announced that Precision NanoSystems (PNI), a Canada-based solution provider, was acquired by its life science business. PNI offered proprietary genetic toolkit platforms, including LNP delivery and nanoparticle manufacturing via the microfluidic-based platform, which further complemented the company's portfolio of life science products.

On the other hand, high operational costs hinder the microfluidics market growth to a certain extent. The fabrication of microfluidics chips has certain issues such as open channel construction that require bonding of machine parts to form a final enclosed structure. The open channel is formed by the etching of glass or silicon. This step is slow, costly, and requires the use of aggressive chemicals. In addition, most of the microfluidic prototyping methods are not compatible with the batch process, and are also complicated and costly.

Microfluidics Market Report Highlights:

  • Based on application, the medical segment held the highest revenue share of the market in 2023 and is expected to exhibit a CAGR of 12.56% from 2024-2030.
  • Based on material, the polydimethylsiloxane (PDMS) segment held the highest market share in 2023 and is expected to grow at a CAGR of 13.59% from 2024-2030.
  • Based on technology, the lab-on-a-chip segment dominated the market in 2023 and is expected to reveal a CAGR of 11.06% during the forecast period.
  • North America dominated the market with a revenue share of 42.69% in 2023 and is projected to exhibit a CAGR of 10.57% during the forecast period.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Information Analysis
    • 1.2.2. Market Application & Data Visualization
    • 1.2.3. Data Validation & Publishing
  • 1.3. Research Assumptions
  • 1.4. Information Procurement
    • 1.4.1. Primary Research
  • 1.5. Information or Data Analysis
  • 1.6. Market Application & Validation
  • 1.7. Market Model
  • 1.8. Global Market: CAGR Calculation
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing demand for low-volume sample analysis
      • 3.2.1.2. Growing penetration of microfluidics in diagnostics market
      • 3.2.1.3. Introduction of advanced technologies
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High operational cost
      • 3.2.2.2. Interfacing and integration
      • 3.2.2.3. Complex fabrication process
    • 3.2.3. Market Opportunity Analysis
      • 3.2.3.1. Investments by companies in technological advancements
      • 3.2.3.2. Growing adoption of point-of-care (POC) tests
      • 3.2.3.3. Expansion of application scope for microfluidics technology
  • 3.3. Industry Analysis Tools
    • 3.3.1. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
    • 3.3.2. Porter's Five Forces Analysis
  • 3.4. COVID-19 Impact Analysis

Chapter 4. Microfluidics Market: Application Business Analysis

  • 4.1. Microfluidics Market: Application Movement Analysis
  • 4.2. Medical
    • 4.2.1. PCR & RT-PCR
      • 4.2.1.1. Global PCR & RT-PCR Market, 2018 - 2030 (USD Million)
    • 4.2.2. Gel electrophoresis
      • 4.2.2.1. Global Gel electrophoresis Market, 2018 - 2030 (USD Million)
    • 4.2.3. Microarrays
      • 4.2.3.1. Global Microarrays Market, 2018 - 2030 (USD Million)
    • 4.2.4. ELISA
      • 4.2.4.1. Global ELISA Market, 2018 - 2030 (USD Million)
    • 4.2.5. Others
      • 4.2.5.1. Global Others Market, 2018 - 2030 (USD Million)
  • 4.3. Non-Medical
    • 4.3.1. Global Non-Medical Market, 2018 - 2030 (USD Million)

Chapter 5. Microfluidics Market: Material Business Analysis

  • 5.1. Microfluidics Market: Material Movement Analysis
  • 5.2. Silicon
    • 5.2.1. Global Silicon Market, 2018 - 2030 (USD Million)
  • 5.3. Glass
    • 5.3.1. Global Glass Market, 2018 - 2030 (USD Million)
  • 5.4. Polymer
    • 5.4.1. Global Polymer Market, 2018 - 2030 (USD Million)
  • 5.5. Polydimethylsiloxane (PDMS)
    • 5.5.1. Global Polydimethylsiloxane (PDMS) Market, 2018 - 2030 (USD Million)
  • 5.6. Others
    • 5.6.1. Global Others Market, 2018 - 2030 (USD Million)

Chapter 6. Microfluidics Market: Technology Business Analysis

  • 6.1. Microfluidics Market: Technology Movement Analysis
  • 6.2. Lab-on-a-chip
    • 6.2.1. Global Lab-on-a-chip Market, 2018 - 2030 (USD Million)
    • 6.2.2. Medical
      • 6.2.2.1. Medical Market, 2018 - 2030 (USD Million)
    • 6.2.3. Non-medical
      • 6.2.3.1. Non-medical Market, 2018 - 2030 (USD Million)
  • 6.3. Organs-on-chips
    • 6.3.1. Global Organs-on-chips Market, 2018 - 2030 (USD Million)
    • 6.3.2. Medical
      • 6.3.2.1. Medical Market, 2018 - 2030 (USD Million)
    • 6.3.3. Non-medical
      • 6.3.3.1. Non-medical Market, 2018 - 2030 (USD Million)
  • 6.4. Continuous flow microfluidics
    • 6.4.1. Global Continuous Flow Microfluidics Market, 2018 - 2030 (USD Million)
    • 6.4.2. Medical
      • 6.4.2.1. Medical Market, 2018 - 2030 (USD Million)
    • 6.4.3. Non-medical
      • 6.4.3.1. Non-medical Market, 2018 - 2030 (USD Million)
  • 6.5. Optofluidics and microfluidics
    • 6.5.1. Global Optofluidics and microfluidics Market, 2018 - 2030 (USD Million)
    • 6.5.2. Medical
      • 6.5.2.1. Medical Market, 2018 - 2030 (USD Million)
    • 6.5.3. Non-medical
      • 6.5.3.1. Non-medical Market, 2018 - 2030 (USD Million)
  • 6.6. Acoustofluidics and microfluidics
    • 6.6.1. Global Acoustofluidics and microfluidics Market, 2018 - 2030 (USD Million)
    • 6.6.2. Medical
      • 6.6.2.1. Medical Market, 2018 - 2030 (USD Million)
    • 6.6.3. Non-medical
      • 6.6.3.1. Non-medical Market, 2018 - 2030 (USD Million)
  • 6.7. Electrophoresis and microfluidics
    • 6.7.1. Global Electrophoresis and microfluidics Market, 2018 - 2030 (USD Million)
    • 6.7.2. Medical
      • 6.7.2.1. Medical Market, 2018 - 2030 (USD Million)
    • 6.7.3. Non-medical
      • 6.7.3.1. Non-medical Market, 2018 - 2030 (USD Million)

Chapter 7. Regional Business Analysis

  • 7.1. Microfluidics Market Share By Region, 2023 & 2030
  • 7.2. North America
    • 7.2.1. North America Microfluidics Market, 2018 - 2030 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. Key Country Dynamics
      • 7.2.2.2. Target disease prevalence
      • 7.2.2.3. Competitive Scenario
      • 7.2.2.4. Regulatory Framework
      • 7.2.2.5. U.S. Microfluidics Market, 2018 - 2030 (USD Million)
    • 7.2.3. Canada
      • 7.2.3.1. Key Country Dynamics
      • 7.2.3.2. Target disease prevalence
      • 7.2.3.3. Competitive Scenario
      • 7.2.3.4. Regulatory Framework
      • 7.2.3.5. Canada Microfluidics Market, 2018 - 2030 (USD Million)
  • 7.3. Europe
    • 7.3.1. Europe Microfluidics Market, 2018 - 2030 (USD Million)
    • 7.3.2. UK
      • 7.3.2.1. Key Country Dynamics
      • 7.3.2.2. Target disease prevalence
      • 7.3.2.3. Competitive Scenario
      • 7.3.2.4. Regulatory Framework
      • 7.3.2.5. UK Microfluidics Market, 2018 - 2030 (USD Million)
    • 7.3.3. Germany
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Target disease prevalence
      • 7.3.3.3. Competitive Scenario
      • 7.3.3.4. Regulatory Framework
      • 7.3.3.5. Germany Microfluidics Market, 2018 - 2030 (USD Million)
    • 7.3.4. France
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Target disease prevalence
      • 7.3.4.3. Competitive Scenario
      • 7.3.4.4. Regulatory Framework
      • 7.3.4.5. France Microfluidics Market, 2018 - 2030 (USD Million)
    • 7.3.5. Italy
      • 7.3.5.1. Key Country Dynamics
      • 7.3.5.2. Target disease prevalence
      • 7.3.5.3. Competitive Scenario
      • 7.3.5.4. Regulatory Framework
      • 7.3.5.5. Italy Microfluidics Market, 2018 - 2030 (USD Million)
    • 7.3.6. Spain
      • 7.3.6.1. Key Country Dynamics
      • 7.3.6.2. Target disease prevalence
      • 7.3.6.3. Competitive Scenario
      • 7.3.6.4. Regulatory Framework
      • 7.3.6.5. Spain Microfluidics Market, 2018 - 2030 (USD Million)
    • 7.3.7. Denmark
      • 7.3.7.1. Key Country Dynamics
      • 7.3.7.2. Target disease prevalence
      • 7.3.7.3. Competitive Scenario
      • 7.3.7.4. Regulatory Framework
      • 7.3.7.5. Denmark Microfluidics Market, 2018 - 2030 (USD Million)
    • 7.3.8. Sweden
      • 7.3.8.1. Key Country Dynamics
      • 7.3.8.2. Target disease prevalence
      • 7.3.8.3. Competitive Scenario
      • 7.3.8.4. Regulatory Framework
      • 7.3.8.5. Sweden Microfluidics Market, 2018 - 2030 (USD Million)
    • 7.3.9. Norway
      • 7.3.9.1. Key Country Dynamics
      • 7.3.9.2. Target disease prevalence
      • 7.3.9.3. Competitive Scenario
      • 7.3.9.4. Regulatory Framework
      • 7.3.9.5. Norway Microfluidics Market, 2018 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific Microfluidics Market, 2018 - 2030 (USD Million)
    • 7.4.2. Japan
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Target disease prevalence
      • 7.4.2.3. Competitive Scenario
      • 7.4.2.4. Regulatory Framework
      • 7.4.2.5. Japan Microfluidics Market, 2018 - 2030 (USD Million)
    • 7.4.3. China
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Target disease prevalence
      • 7.4.3.3. Competitive Scenario
      • 7.4.3.4. Regulatory Framework
      • 7.4.3.5. China Microfluidics Market, 2018 - 2030 (USD Million)
    • 7.4.4. India
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Target disease prevalence
      • 7.4.4.3. Competitive Scenario
      • 7.4.4.4. Regulatory Framework
      • 7.4.4.5. India Microfluidics Market, 2018 - 2030 (USD Million)
    • 7.4.5. Australia
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Target disease prevalence
      • 7.4.5.3. Competitive Scenario
      • 7.4.5.4. Regulatory Framework
      • 7.4.5.5. Australia Microfluidics Market, 2018 - 2030 (USD Million)
    • 7.4.6. Thailand
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Target disease prevalence
      • 7.4.6.3. Competitive Scenario
      • 7.4.6.4. Regulatory Framework
      • 7.4.6.5. Thailand Microfluidics Market, 2018 - 2030 (USD Million)
    • 7.4.7. South Korea
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Target disease prevalence
      • 7.4.7.3. Competitive Scenario
      • 7.4.7.4. Regulatory Framework
      • 7.4.7.5. South Korea Microfluidics Market, 2018 - 2030 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Latin America Microfluidics Market, 2018 - 2030 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Target disease prevalence
      • 7.5.2.3. Competitive Scenario
      • 7.5.2.4. Regulatory Framework
      • 7.5.2.5. Brazil Microfluidics Market, 2018 - 2030 (USD Million)
    • 7.5.3. Mexico
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Target disease prevalence
      • 7.5.3.3. Competitive Scenario
      • 7.5.3.4. Regulatory Framework
      • 7.5.3.5. Mexico Microfluidics Market, 2018 - 2030 (USD Million)
    • 7.5.4. Argentina
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Target disease prevalence
      • 7.5.4.3. Competitive Scenario
      • 7.5.4.4. Regulatory Framework
      • 7.5.4.5. Argentina Microfluidics Market, 2018 - 2030 (USD Million)
  • 7.6. MEA
    • 7.6.1. MEA Microfluidics Market, 2018 - 2030 (USD Million)
    • 7.6.2. South Africa
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Target disease prevalence
      • 7.6.2.3. Competitive Scenario
      • 7.6.2.4. Regulatory Framework
      • 7.6.2.5. South Africa Microfluidics Market, 2018 - 2030 (USD Million)
    • 7.6.3. Saudi Arabia
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Target disease prevalence
      • 7.6.3.3. Competitive Scenario
      • 7.6.3.4. Regulatory Framework
      • 7.6.3.5. Saudi Arabia Microfluidics Market, 2018 - 2030 (USD Million)
    • 7.6.4. UAE
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Target disease prevalence
      • 7.6.4.3. Competitive Scenario
      • 7.6.4.4. Regulatory Framework
      • 7.6.4.5. UAE Microfluidics Market, 2018 - 2030 (USD Million)
    • 7.6.5. Kuwait
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Target disease prevalence
      • 7.6.5.3. Competitive Scenario
      • 7.6.5.4. Regulatory Framework
      • 7.6.5.5. Kuwait Microfluidics Market, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Position Analysis, 2023
  • 8.4. Company Profiles
    • 8.4.1. Illumina, Inc.
      • 8.4.1.1. Overview
      • 8.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Strategic Initiatives
    • 8.4.2. F. Hoffmann-La Roche Ltd
      • 8.4.2.1. Overview
      • 8.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Strategic Initiatives
    • 8.4.3. PerkinElmer, Inc
      • 8.4.3.1. Overview
      • 8.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Strategic Initiatives
    • 8.4.4. Agilent Technologies, Inc
      • 8.4.4.1. Overview
      • 8.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Strategic Initiatives
    • 8.4.5. Bio-Rad Laboratories, Inc
      • 8.4.5.1. Overview
      • 8.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Strategic Initiatives
    • 8.4.6. Danaher Corporation
      • 8.4.6.1. Overview
      • 8.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Strategic Initiatives
    • 8.4.7. Abbott
      • 8.4.7.1. Overview
      • 8.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Strategic Initiatives
    • 8.4.8. Thermo Fisher Scientific Inc.
      • 8.4.8.1. Overview
      • 8.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Strategic Initiatives
    • 8.4.9. Standard BioTools, Inc.
      • 8.4.9.1. Overview
      • 8.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Strategic Initiatives

List of Tables

  • Table 1 Some commercialized POCT devices based on NAT.
  • Table 2 List of FDA-approved microfluidic-based POC tests
  • Table 3 Research institutes in Canada working on microfabricated microfluidics
  • Table 4 Overview of magnetic, colorimetric, plasmonic, electrochemical, and lateral flow assays
  • Table 5 Several approaches for microfluidic PCR devices including commercial PCR devices
  • Table 6 Major types of micro mosaic immunoassays
  • Table 7 Particle-focusing techniques applied in microfluidic flow cytometry
  • Table 8 Comparison of detection of food allergens by commercial ELISA kits and the microfluidic ELISA biosensor
  • Table 9 Materials and their respective technologies for micro structuring
  • Table 10 Comparison of polymers with glass
  • Table 11 Distinctive features of continuous-flow microfluidics and their usage in materials synthesis
  • Table 12 Different applications of acoustofluidic separation
  • Table 13 List of established companies
  • Table 14 List of emerging companies (contd.)
  • Table 15 List of Secondary Sources
  • Table 16 List of Abbreviations
  • Table 17 Global Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 18 Global Microfluidics Market, by Material, 2018 - 2030 (USD Million)
  • Table 19 Global Microfluidics Market, by Application, 2018 - 2030 (USD Million)
  • Table 20 Global Microfluidics Market, by Region, 2018 - 2030 (USD Million)
  • Table 21 North America Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 22 North America Microfluidics Market, by Material, 2018 - 2030 (USD Million)
  • Table 23 North America Microfluidics Market, by Application, 2018 - 2030 (USD Million)
  • Table 24 U.S. Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 25 U.S. Microfluidics Market, by Material, 2018 - 2030 (USD Million)
  • Table 26 U.S. Microfluidics Market, by Application, 2018 - 2030 (USD Million)
  • Table 27 Canada Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 28 Canada Microfluidics Market, by Material, 2018 - 2030 (USD Million)
  • Table 29 Canada Microfluidics Market, by Application, 2018 - 2030 (USD Million)
  • Table 30 Europe Microfluidics Market, by Country, 2018 - 2030 (USD Million)
  • Table 31 Europe Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 32 Europe Microfluidics Market, by Material, 2018 - 2030 (USD Million)
  • Table 33 Europe Microfluidics Market, by Application, 2018 - 2030 (USD Million)
  • Table 34 Germany Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 35 Germany Microfluidics Market, by Material, 2018 - 2030 (USD Million)
  • Table 36 Germany Microfluidics Market, by Application, 2018 - 2030 (USD Million)
  • Table 37 UK Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 38 UK Microfluidics Market, by Material, 2018 - 2030 (USD Million)
  • Table 39 UK Microfluidics Market, by Application, 2018 - 2030 (USD Million)
  • Table 40 Norway Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 41 Norway Microfluidics Market, by Material, 2018 - 2030 (USD Million)
  • Table 42 Norway Microfluidics Market, by Application, 2018 - 2030 (USD Million)
  • Table 43 Sweden Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 44 Sweden Microfluidics Market, by Material, 2018 - 2030 (USD Million)
  • Table 45 Sweden Microfluidics Market, by Application, 2018 - 2030 (USD Million)
  • Table 46 Denmark Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 47 Denmark Microfluidics Market, by Material, 2018 - 2030 (USD Million)
  • Table 48 Denmark Microfluidics Market, by Application, 2018 - 2030 (USD Million)
  • Table 49 France Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 50 France Microfluidics Market, by Material, 2018 - 2030 (USD Million)
  • Table 51 France Microfluidics Market, by Application, 2018 - 2030 (USD Million)
  • Table 52 Italy Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 53 Italy Microfluidics Market, by Material, 2018 - 2030 (USD Million)
  • Table 54 Italy Microfluidics Market, by Application, 2018 - 2030 (USD Million)
  • Table 55 Asia Pacific Microfluidics Market, by Country, 2018 - 2030 (USD Million)
  • Table 56 Asia Pacific Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 57 Asia Pacific Microfluidics Market, by Material, 2018 - 2030 (USD Million)
  • Table 58 Asia Pacific Microfluidics Market, by Application, 2018 - 2030 (USD Million)
  • Table 59 China Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 60 China Microfluidics Market, by Material, 2018 - 2030 (USD Million)
  • Table 61 China Microfluidics Market, by Application, 2018 - 2030 (USD Million)
  • Table 62 Japan Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 63 Japan Microfluidics Market, by Material, 2018 - 2030 (USD Million)
  • Table 64 Japan Microfluidics Market, by Application, 2018 - 2030 (USD Million)
  • Table 65 India Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 66 India Microfluidics Market, by Material, 2018 - 2030 (USD Million)
  • Table 67 India Microfluidics Market, by Application, 2018 - 2030 (USD Million)
  • Table 68 Australia Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 69 Australia Microfluidics Market, by Material, 2018 - 2030 (USD Million)
  • Table 70 Australia Microfluidics Market, by Application, 2018 - 2030 (USD Million)
  • Table 71 Thailand Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 72 Thailand Microfluidics Market, by Material, 2018 - 2030 (USD Million)
  • Table 73 Thailand Microfluidics Market, by Application, 2018 - 2030 (USD Million)
  • Table 74 Latin America Microfluidics Market, by Country, 2018 - 2030 (USD Million)
  • Table 75 Latin America Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 76 Latin America Microfluidics Market, by Material, 2018 - 2030 (USD Million)
  • Table 77 Latin America Microfluidics Market, by Application, 2018 - 2030 (USD Million)
  • Table 78 Brazil Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 79 Brazil Microfluidics Market, by Material, 2018 - 2030 (USD Million)
  • Table 80 Brazil Microfluidics Market, by Application, 2018 - 2030 (USD Million)
  • Table 81 Mexico Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 82 Mexico Microfluidics Market, by Material, 2018 - 2030 (USD Million)
  • Table 83 Mexico Microfluidics Market, by Application, 2018 - 2030 (USD Million)
  • Table 84 Argentina Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 85 Argentina Microfluidics Market, by Material, 2018 - 2030 (USD Million)
  • Table 86 Argentina Microfluidics Market, by Application, 2018 - 2030 (USD Million)
  • Table 87 Middle East & Africa Microfluidics Market, by Country, 2018 - 2030 (USD Million)
  • Table 88 Middle East & Africa Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 89 Middle East & Africa Microfluidics Market, by Material, 2018 - 2030 (USD Million)
  • Table 90 Middle East & Africa Microfluidics Market, by Application, 2018 - 2030 (USD Million)
  • Table 91 South Africa Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 92 South Africa Microfluidics Market, by Material, 2018 - 2030 (USD Million)
  • Table 93 South Africa Microfluidics Market, by Application, 2018 - 2030 (USD Million)
  • Table 94 Saudi Arabia Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 95 Saudi Arabia Microfluidics Market, by Material, 2018 - 2030 (USD Million)
  • Table 96 Saudi Arabia Microfluidics Market, by Application, 2018 - 2030 (USD Million)
  • Table 97 UAE Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 98 UAE Microfluidics Market, by Material, 2018 - 2030 (USD Million)
  • Table 99 UAE Microfluidics Market, by Application, 2018 - 2030 (USD Million)
  • Table 100 Kuwait Microfluidics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 101 Kuwait Microfluidics Market, by Material, 2018 - 2030 (USD Million)
  • Table 102 Kuwait Microfluidics Market, by Application, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Information procurement
  • Fig. 2 Primary research pattern
  • Fig. 3 Market research approaches
  • Fig. 4 Value-chain-based sizing & forecasting
  • Fig. 5 QFD modeling for market share assessment
  • Fig. 6 Market formulation & validation
  • Fig. 7 Microfluidics market estimation process
  • Fig. 8 Market snapshot
  • Fig. 9 Market trends & outlook
  • Fig. 10 Microfluidics market segmentation
  • Fig. 11 Penetration and growth prospect mapping
  • Fig. 12 SWOT analysis, by factor (Political & legal, economic, and technological)
  • Fig. 13 Porter's five forces analysis
  • Fig. 14 Market driver impact
  • Fig. 15 Market restraint impact
  • Fig. 16 Emerging applications of automated and miniaturized microfluidics
  • Fig. 17 Companies developing automated and miniaturized microfluidics
  • Fig. 18 Extending applications of microfluidics technology
  • Fig. 19 Photolithographic procedure
  • Fig. 20 Types of COVID-19 tests
  • Fig. 21 Advantages of lab-on-chip devices for COVID-19 testing
  • Fig. 22 Microfluidics market: technology outlook and key takeaways
  • Fig. 23 Microfluidics market: technology movement analysis
  • Fig. 24 Microfluidics market estimates and forecast for medical technologies, 2018 - 2030 (USD Million)
  • Fig. 25 Microfluidics market estimates and forecast for PCR & RT-PCR, 2018 - 2030 (USD Million)
  • Fig. 26 Microfluidics market estimates and forecast for gel electrophoresis, 2018 - 2030 (USD Million)
  • Fig. 27 Microfluidics market estimates and forecast for microarrays, 2018 - 2030 (USD Million)
  • Fig. 28 Microfluidics market estimates and forecast for ELISA, 2018 - 2030 (USD Million)
  • Fig. 29 Different detection methods for microfluidic flow cytometry
  • Fig. 30 Microfluidics market estimates and forecast for other technologies, 2018 - 2030 (USD Million)
  • Fig. 31 Microfluidics market estimates and forecast for non-medical technologies, 2018 - 2030 (USD Million)
  • Fig. 32 Microfluidics market: material outlook and key takeaways
  • Fig. 33 Microfluidics market: material movement analysis
  • Fig. 34 Pros and cons of silicon
  • Fig. 35 Microfluidics market estimates and forecast for silicon, 2018 - 2030 (USD Million)
  • Fig. 36 Advantages of glass as microfluidic material
  • Fig. 37 Microfluidics market estimates and forecast for glass, 2018 - 2030 (USD Million)
  • Fig. 38 Types of polymers used to develop microfluidic devices
  • Fig. 39 Microfluidics market estimates and forecast for polymer, 2018 - 2030 (USD Million)
  • Fig. 40 Microfluidics market estimates and forecast for PDMS, 2018 - 2030 (USD Million)
  • Fig. 41 Microfluidics market estimates and forecast for other materials, 2018 - 2030 (USD Million)
  • Fig. 42 Microfluidics market: application outlook and key takeaways
  • Fig. 43 Microfluidics market: Application movement analysis
  • Fig. 44 Microfluidics market estimates and forecast for lab-on-a-chip, 2018 - 2030 (USD Million)
  • Fig. 45 Medical lab-on-a-chip market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 46 Non-medical lab-on-a-chip market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 47 Microfluidics market estimates and forecast for organs-on-chip, 2018 - 2030 (USD Million)
  • Fig. 48 Medical organs-on-chip market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 49 Non-medical organs-on-chip market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 50 Microfluidics market estimates and forecast for continuous flow microfluidics, 2018 - 2030 (USD Million)
  • Fig. 51 Medical continuous flow microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 52 Non-medical continuous flow microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 53 Microfluidics market estimates and forecast for optofluidics and microfluidics, 2018 - 2030 (USD Million)
  • Fig. 54 Medical optofluidics and microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 55 Non-medical optofluidics and microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 56 Microfluidics market estimates and forecast for acoustofluidics and microfluidics, 2018 - 2030 (USD Million)
  • Fig. 57 Medical applications of acoustofluidics
  • Fig. 58 Medical acoustofluidics and microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 59 Non-medical acoustofluidics and microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 60 Microfluidics market estimates and forecast for electrophoresis and microfluidics, 2018 - 2030 (USD Million)
  • Fig. 61 Medical electrophoresis and microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 62 Non-medical electrophoresis and microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 63 Regional marketplace: regional outlook and key takeaways
  • Fig. 64 Microfluidics regional outlook, 2021 & 2030
  • Fig. 65 North America microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 66 U.S. microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 67 Canada microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 68 Europe microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 69 Germany microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 70 UK microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 71 France microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 72 Italy microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 73Denmark microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 74 Norway microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 75 Sweden microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 76 Asia Pacific microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 77 Japan microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 78 China microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 79 India microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 80 Australia microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 81 Thailand microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 82 Latin America microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 83 Brazil microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 84 Mexico microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 85 Argentina microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 86 MEA microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 87 South Africa microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 88 Saudi Arabia microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 89 UAE microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 90 Kuwait microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 91 Strategy framework
  • Fig. 92 Participant categorization